These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17662910)

  • 21. Willingness-to-pay and quality of life in patients with vitiligo.
    Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
    Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial grafting for vitiligo requires ultraviolet A phototherapy to increase success rate.
    Awad SS; Abdel-Raof H; Hosam El-Din W; El-Domyati M
    J Cosmet Dermatol; 2007 Jun; 6(2):119-24. PubMed ID: 17524129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire.
    Augustin M; Gajur AI; Reich C; Rustenbach SJ; Schaefer I
    Dermatology; 2008; 217(2):101-6. PubMed ID: 18451647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What you need to know about .... vitiligo.
    Nurs Times; 2003 Dec 9-15; 99(49):27. PubMed ID: 14705342
    [No Abstract]   [Full Text] [Related]  

  • 25. Focus Theme Issue: "Vitiligo and other pigmentary disorders".
    Picardo M; Taïeb A
    Exp Dermatol; 2019 Jun; 28(6):639-641. PubMed ID: 31215722
    [No Abstract]   [Full Text] [Related]  

  • 26. Psychosocial effect of vitiligo: a comparison of vitiligo patients with "normal" control subjects, with psoriasis patients, and with patients with other pigmentary disorders.
    Porter JR; Beuf AH; Lerner A; Nordlund J
    J Am Acad Dermatol; 1986 Aug; 15(2 Pt 1):220-4. PubMed ID: 3745526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pigmentary disorders in Latin America.
    Falabella R
    Dermatol Clin; 2007 Jul; 25(3):419-30, x. PubMed ID: 17662907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitiligo treatment with a combination of PUVA therapy and epidermal autografts.
    Skouge J; Morison WL
    Arch Dermatol; 1995 Nov; 131(11):1257-8. PubMed ID: 7503568
    [No Abstract]   [Full Text] [Related]  

  • 29. A rational approach to the treatment of vitiligo and other hypomelanoses.
    Hercogová J; Buggiani G; Prignano F; Lotti T
    Dermatol Clin; 2007 Jul; 25(3):383-92, ix. PubMed ID: 17662904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stigma experience in skin disorders: an Indian perspective.
    Chaturvedi SK; Singh G; Gupta N
    Dermatol Clin; 2005 Oct; 23(4):635-42. PubMed ID: 16112439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pigmentary disorders in India.
    Pasricha JS; Khaitan BK; Dash S
    Dermatol Clin; 2007 Jul; 25(3):343-52, viii. PubMed ID: 17662900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychosocial effects of vitiligo.
    Ongenae K; Beelaert L; van Geel N; Naeyaert JM
    J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):1-8. PubMed ID: 16405601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vitiligo in children].
    Lacour JP
    Ann Pediatr (Paris); 1988 May; 35(5):313-9. PubMed ID: 3400965
    [No Abstract]   [Full Text] [Related]  

  • 34. Vitiligo: the historical curse of depigmentation.
    Millington GW; Levell NJ
    Int J Dermatol; 2007 Sep; 46(9):990-5. PubMed ID: 17822509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of categories at risk for high quality of life impairment in patients with vitiligo.
    Sampogna F; Raskovic D; Guerra L; Pedicelli C; Tabolli S; Leoni L; Alessandroni L; Abeni D
    Br J Dermatol; 2008 Aug; 159(2):351-9. PubMed ID: 18565189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing the knowledge in managing hyperpigmentary disorders: a report from the Pigmentary Disorders Academy.
    Ortonne JP
    Br J Dermatol; 2006 Dec; 156 Suppl 1():1-2. PubMed ID: 17176297
    [No Abstract]   [Full Text] [Related]  

  • 37. The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology.
    Njoo MD; Westerhof W; Bos JD; Bossuyt PM
    Arch Dermatol; 1999 Dec; 135(12):1514-21. PubMed ID: 10606057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre.
    Kostopoulou P; Jouary T; Quintard B; Ezzedine K; Marques S; Boutchnei S; Taieb A
    Br J Dermatol; 2009 Jul; 161(1):128-33. PubMed ID: 19298280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of childhood vitiligo on adult life.
    Linthorst Homan MW; de Korte J; Grootenhuis MA; Bos JD; Sprangers MA; van der Veen JP
    Br J Dermatol; 2008 Sep; 159(4):915-20. PubMed ID: 18717679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 'EpiEnlist' project: a dermo-epidemiologic study on a representative sample of young Italian males. Prevalence of selected pigmentary lesions.
    Ingordo V; Gentile C; Iannazzone SS; Cusano F; Naldi L
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1091-6. PubMed ID: 17714131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.